24.49
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Automated trading signals detected on Oruka Therapeutics Inc.Options Play & Safe Capital Investment Plans - newser.com
Oruka Therapeutics (NASDAQ:ORKA) Trading Up 7.5%Should You Buy? - MarketBeat
Oruka Therapeutics (ORKA) Is Up 33.2% After Announcing $1.25B Shelf Registration and $200M Offering - Yahoo Finance
Weiss Ratings Reiterates Sell (D-) Rating for Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat
How Oruka Therapeutics Inc. (HQ1) stock reacts to monetary easingBull Run & Weekly Top Gainers Trade List - newser.com
Why retail traders accumulate Oruka Therapeutics Inc. (HQ1) stockMarket Risk Summary & Daily Chart Pattern Signals - newser.com
How Oruka Therapeutics Inc. stock performs in stagflationLong Setup & Consistent Income Trade Ideas - newser.com
Can a trend reversal in Oruka Therapeutics Inc. lead to recoveryWeekly Stock Analysis & Community Consensus Picks - newser.com
What drives Oruka Therapeutics Inc stock priceMarket Entry Points & Budget Investment Success - earlytimes.in
Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday - Benzinga
How reliable is Oruka Therapeutics Inc. (HQ1) stock dividend growthSwing Trade & Advanced Technical Analysis Signals - newser.com
Should you wait for a breakout in Oruka Therapeutics Inc.Take Profit & Capital Efficiency Focused Ideas - newser.com
Oruka Therapeutics Inc Stock Analysis and ForecastValue Stock Picks & Free Real-Time Trading Alerts Every Day - earlytimes.in
Oruka Therapeutics files to sell 39.43M shares of common stock for holders - MSN
Oruka Therapeutics files for mixed shelf of upto $500 millionSEC filing - MarketScreener
Is Oruka Therapeutics Inc. forming a bottoming baseJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
Custom strategy builders for tracking Oruka Therapeutics Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
What drives Oruka Therapeutics Inc HQ1 stock priceDividend Stability Analysis & Budget Friendly Growth - earlytimes.in
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $56 - 富途牛牛
MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades - Stocktwits
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpWhat's Next? - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Receives Buy Rating from BTIG Research - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):